The U.S. Environmental Protection Agency (EPA) has recently approved a Section 18 Public Health Emergency Exemption for the use of Grignard Pure, an antimicrobial air treatment solution, for intrastate transit and transportation applications in Texas, Nevada, Pennsylvania and Maryland. Administered through Luminator Technology Group’s (Luminator) Renew Air Treatment System, the solution provides continuous protection against SARS-CoV-2.
The EPA’s Section 18 emergency exemption for Grignard Pure was approved for use in Georgia and Tennessee earlier. This is now authorized for use in Texas, Nevada, Pennsylvania and Maryland. This approval applies to its use in specific indoor spaces (occupied and unoccupied) when adherence to current public health guidelines is impractical or difficult to maintain (e.g., CDC guidance at www.cdc.gov recommending social distancing, limited occupancy and increased ventilation). Approved use sites in Texas, Nevada, Pennsylvania and Maryland include intrastate transportation. Complete listing is available at EPA’s website.
When deployed in mass transit environments, the system will help protect passengers, operators and other transit employees from the spread of the virus that causes COVID-19. Grignard Pure is dispensed on-board transit bus and rail vehicles through an adaptive system manufactured by Luminator.
Grignard Pure is proven to kill 98% of SARS-CoV-2 virus particles in the air, where transmission is most likely. When in use, it delivers continuously effective protection of indoor occupied and unoccupied spaces, including transit buses and railcars.
